Management of postoperative nausea and vomiting: focus on palonosetron
N. A. Muchatuta, M. J. Paech
openalex +1 more source
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II) [PDF]
Kenichi Suzuki +14 more
openalex +1 more source
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Navari RM +7 more
europepmc +1 more source
Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report. [PDF]
Kanno R +5 more
europepmc +1 more source
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]
Dhabhar B +10 more
europepmc +1 more source
Effect of closed-chain isometric plyometric training combined with palonosetron on postoperative knee function in patients after total knee arthroplasty. [PDF]
Shao J +5 more
europepmc +1 more source
Palonosetron Improves Dietary Intake Compared to Granisetron in Patients Undergoing Highly Emetogenic Chemotherapy [PDF]
Nobuhiro Shibata +7 more
openalex +1 more source
Comment on "Comparison of efficacy and safety between palonosetron and ondansetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a systematic review and meta-analysis". [PDF]
Kang HY.
europepmc +1 more source

